Goldman Sachs Upgrades Genmab A/S (GMAB) to Buy

Goldman Sachs analyst Rajan Sharma upgraded Genmab A/S (NASDAQ: GMAB) from Neutral to Buy with a price target of $30.50 (from $24.50).

For an analyst ratings summary and ratings history on Genmab A/S click here. For more ratings news on Genmab A/S click here.

Shares of Genmab A/S closed at $27.06 yesterday.

You May Also Be Interested In

• Genmab A/S (GMAB) PT Raised to $40 at H.C. Wainwright
• JFrog (FROG) PT Raised to $110 at UBS as Checks Point to 'Solid Demand Backdrop'
• ICICI Securities Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Reduce (4)